bacteremia


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

bac·te·re·mi·a

 (băk′tə-rē′mē-ə)
n.
The presence of bacteria in the blood.

bac′te·re′mic (-mĭk) adj.
bac′te·re′mi·cal·ly adv.

bac•te•re•mi•a

(ˌbæk təˈri mi ə)

n.
the presence of bacteria in the blood.
[1885–90]
bac`te•re′mic (-mɪk) adj.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.bacteremia - transient presence of bacteria (or other microorganisms) in the bloodbacteremia - transient presence of bacteria (or other microorganisms) in the blood
microorganism, micro-organism - any organism of microscopic size
pathology - any deviation from a healthy or normal condition
Translations

bacteremia

n bacteriemia
References in periodicals archive ?
MONDAY, July 8, 2019 (HealthDay News) -- The prevalence of infective endocarditis (IE) is about 26 percent among patients with Enterococcus faecalis bacteremia, according to a study published in the July 16 issue of the Journal of the American College of Cardiology.
cereus causes severe nongastrointestinal infections, such as bacteremia (2), endocarditis (3), meningoencephalitis (4), and pneumonia (5).
ContraFect announced that new data from its Phase 2 clinical trial of exebacase for the treatment of Staphylococcus aureus bacteremia including endocarditis was presented by Vance Fowler, M.D., Professor of Medicine in the Division of Infectious Diseases, Duke University at a late-breaker session at the 29th European Congress of Clinical Microbiology and Infectious Diseases, or ECCMID.
aureus bacteremia in a case with late prosthesis infection and atypical complaints.
The prevalence of the complicated UTI including bacteremia increases with age.1,2 The prevalence is high among elders with diabetes.
Infants with bacteremia caused by group B streptococcus (GBS) who were treated with intravenous antimicrobial therapy for 8 days or less had similarly successful outcomes, compared with those treated longer, based on data from 775 infants.
In-hospital TB-related mortality rate was 19% (4/21) among MTBC-bacteremia patients and 4.8% (6/124) in those with no bacteremia (p = 0.017) (Table 1).
Tigecycline is an alternative for MDR Acinetobacter baumannii and Klebsiella pneumoniae carbapenemase-producing bacteria (KPC), but it is not recommended for bacteremia because it does not achieve adequate serum concentration levels and is associated to an increased risk of death (4-5).
Therefore, our study aimed to investigate the association of bacteremia with in-hospital mortality and the risk factors for bacteremia in cirrhotic patients with UGIB to assist decision-making for preventing complications, such as pneumonia and other infections, and treatment strategies of antibiotics use in the emergency department (ED).
Many different risk factors contributing to candidemia and bacteremia have been reported in several studies (3-10).
Despite colistin and tigecycline as the last resorts, the optimal therapeutic regimen of CRAB bacteremia has not been established, and the unavailability of new antibiotic pipeline in developing countries definitely restricts clinical therapeutic options and facilitates its dissemination.